+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: May 2022 | From USD $2900 | Published By: GLOBAL DATA | Number Of Pages: 143
Liver Failure (Hepatic Insufficiency) (Gastrointestinal) - Drugs in Development, 2021
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure - Drugs In Development, 2021, provides an overview of the Liver Failure (Gastrointestinal) pipeline landscape.
Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, tendency to bruise or bleed easily, ascites, impaired brain function (encephalopathy), poor weight gain and growth, fatigue, weakness, nausea and loss of appetite. Since these symptoms are associated with a host of other conditions, it may take some time before the correct diagnosis is made. As liver failure worsens, people may experience disorientation and drowsiness. At this stage, there is a risk of coma and death.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Liver Failure - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Liver Failure (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Liver Failure (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Failure (Hepatic Insufficiency) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Unknown stages are 2, 13, 14 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Liver Failure (Gastrointestinal) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Liver Failure (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Liver Failure (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Liver Failure (Gastrointestinal) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Liver Failure (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Liver Failure (Gastrointestinal)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Liver Failure (Gastrointestinal).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Liver Failure (Gastrointestinal) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Introduction
Global Markets Direct Report Coverage
Liver Failure - Overview
Liver Failure - Therapeutics Development
Liver Failure - Therapeutics Assessment
Liver Failure - Companies Involved in Therapeutics Development
Liver Failure - Drug Profiles
Liver Failure - Dormant Projects
Liver Failure - Discontinued Products
Liver Failure - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Liver Failure (Hepatic Insufficiency), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Arch Biopartners Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Bopin (Shanghai) Biomedical Technology Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Bristol-Myers Squibb Co, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Creative Medical Technology Holdings Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by EA Pharma Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Egetis Therapeutics AB, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Evive Biotech, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Galmed Pharmaceuticals Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by GoLiver Therapeutics, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by HepaRegeniX GmbH, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Hepatx Corp, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Immune Pharmaceuticals Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Martin Pharmaceuticals Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Mina Therapeutics Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Novartis AG, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Orgenesis Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Promethera Biosciences SA, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Proterris Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Rejuvenation Technologies Inc, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by SK Biopharmaceuticals Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Takeda Pharmaceutical Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by The Healthy Aging Co, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Tianjin Angsai Cell Genetic Engineering Co Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Tianjin Weikai Bioeng Ltd, 2021
Liver Failure (Hepatic Insufficiency) - Pipeline by Unicyte AG, 2021
Liver Failure (Hepatic Insufficiency) - Dormant Projects, 2021
Liver Failure (Hepatic Insufficiency) - Dormant Projects, 2021 (Contd..1)
Liver Failure (Hepatic Insufficiency) - Discontinued Products, 2021
List of Figures
Number of Products under Development for Liver Failure (Hepatic Insufficiency), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
